Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the complete record of transactions filed by Hallam Trevor, Autre. Director active across 1 company, notably Sutro Biopharma, INC.. Aggregated, 7 reports have been logged. Activity tracked since 24 September 2021. The latest transaction was filed on 14 April 2023 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations
Hallam Trevor is an other declarant linked to Sutro Biopharma, INC. (XNAS), where the listed role is Pres. Rsrch & Cf. Sctific Ofcr. The record shows 7 filings, all in the sampled set, between 2021-09-28 and 2023-04-17, with Levée d'options as the stated transaction nature. The buy and sell amounts shown for these recent filings are 0 and 0.